Shing M. Lee

3.3k total citations
75 papers, 2.3k citations indexed

About

Shing M. Lee is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Shing M. Lee has authored 75 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Statistics and Probability, 21 papers in Pulmonary and Respiratory Medicine and 14 papers in Economics and Econometrics. Recurrent topics in Shing M. Lee's work include Statistical Methods in Clinical Trials (22 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Cancer Genomics and Diagnostics (9 papers). Shing M. Lee is often cited by papers focused on Statistical Methods in Clinical Trials (22 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Cancer Genomics and Diagnostics (9 papers). Shing M. Lee collaborates with scholars based in United States, France and United Kingdom. Shing M. Lee's co-authors include Ying Kuen Cheung, Robert A. Wise, Frank C. Sciurba, Zab Mohsenifar, Gerard J. Criner, William A. Slivka, David Shade, Mark L. Gonzalgo, William G. Nelson and Christian P. Pavlovich and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Physical review. B, Condensed matter.

In The Last Decade

Shing M. Lee

75 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shing M. Lee United States 26 748 348 335 294 286 75 2.3k
Heloisa P. Soares United States 25 775 1.0× 1.2k 3.5× 652 1.9× 250 0.9× 143 0.5× 100 3.4k
Patrik Finne Finland 39 999 1.3× 482 1.4× 678 2.0× 115 0.4× 74 0.3× 131 3.8k
Julien Péron France 28 453 0.6× 1.0k 2.9× 207 0.6× 100 0.3× 244 0.9× 121 2.1k
Yann De Rycke France 30 959 1.3× 1000 2.9× 525 1.6× 622 2.1× 170 0.6× 105 3.3k
Benoît You France 33 578 0.8× 1.3k 3.9× 462 1.4× 125 0.4× 159 0.6× 231 3.3k
J. Michaelis Germany 32 727 1.0× 521 1.5× 302 0.9× 309 1.1× 32 0.1× 87 3.8k
Xiaofei Wang United States 25 1.3k 1.7× 866 2.5× 238 0.7× 75 0.3× 175 0.6× 93 2.2k
Fay Cafferty United Kingdom 22 578 0.8× 523 1.5× 401 1.2× 110 0.4× 62 0.2× 56 2.0k
Mohamad Bassam Sonbol United States 27 560 0.7× 1.1k 3.3× 435 1.3× 262 0.9× 34 0.1× 133 2.5k
Stefania Galimberti Italy 28 549 0.7× 463 1.3× 319 1.0× 77 0.3× 33 0.1× 109 2.7k

Countries citing papers authored by Shing M. Lee

Since Specialization
Citations

This map shows the geographic impact of Shing M. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shing M. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shing M. Lee more than expected).

Fields of papers citing papers by Shing M. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shing M. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shing M. Lee. The network helps show where Shing M. Lee may publish in the future.

Co-authorship network of co-authors of Shing M. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Shing M. Lee. A scholar is included among the top collaborators of Shing M. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shing M. Lee. Shing M. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Shing M., et al.. (2024). U-PRO-CRM: designing patient-centred dose-finding trials with patient-reported outcomes. ESMO Open. 9(7). 103626–103626. 4 indexed citations
2.
Ingham, Matthew, Li Chen, Biswajit Das, et al.. (2024). Correlative results from NCI CTEP/ETCTN 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for advanced conventional chondrosarcoma (cCS).. Journal of Clinical Oncology. 42(16_suppl). 11526–11526. 3 indexed citations
3.
Lee, Shing M., Weijia Fan, Aijin Wang, et al.. (2023). Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO Clinical Cancer Informatics. 7(7). e2200165–e2200165. 2 indexed citations
4.
Beauchemin, Melissa, Shing M. Lee, Melissa Accordino, et al.. (2023). Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs. JCO Oncology Practice. 20(1). 85–92. 2 indexed citations
5.
Beauchemin, Melissa, Shing M. Lee, Melissa Accordino, et al.. (2022). Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer Drugs. JCO Oncology Practice. 19(3). e326–e335. 5 indexed citations
6.
Ingham, Matthew, Shing M. Lee, Brian A. Van Tine, et al.. (2022). A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma. Clinical Cancer Research. 29(6). 1031–1039. 8 indexed citations
7.
Lee, Shing M., et al.. (2019). A comparison of nurses’ and physicians’ perception of cancer treatment burden based on reported adverse events. Health and Quality of Life Outcomes. 17(1). 146–146. 3 indexed citations
8.
Fenn, Kathleen, Matthew Maurer, Shing M. Lee, et al.. (2019). Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer. Clinical Breast Cancer. 20(1). 80–86. 26 indexed citations
9.
Liu, Ying L., Christine Choi, Shing M. Lee, et al.. (2017). Invasive Lobular Breast Carcinoma: Pleomorphic Versus Classical Subtype, Associations and Prognosis. Clinical Breast Cancer. 18(2). 114–120. 13 indexed citations
10.
Johnson, Denise, et al.. (2016). A comparison of prevaginal and postvaginal manipulation fetal fibronectin. American Journal of Obstetrics and Gynecology. 214(5). 646.e1–646.e6. 3 indexed citations
11.
Liu, Ying L., Anurag Saraf, Shing M. Lee, et al.. (2016). Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 157(3). 555–564. 50 indexed citations
12.
Wright, Jason D., Sharyn N. Lewin, Monjri Shah, et al.. (2011). Quality of Venous Thromboembolism Prophylaxis in Patients Undergoing Oncologic Surgery. Annals of Surgery. 253(6). 1140–1146. 30 indexed citations
13.
Zafonte, Ross, William T. Friedewald, Shing M. Lee, et al.. (2009). The Citicoline Brain Injury Treatment (COBRIT) Trial: Design and Methods. Journal of Neurotrauma. 26(12). 2207–2216. 53 indexed citations
14.
Hesdorffer, Mary, John A. Chabot, Mary Louise Keohan, et al.. (2008). Combined Resection, Intraperitoneal Chemotherapy, and Whole Abdominal Radiation for the Treatment of Malignant Peritoneal Mesothelioma. American Journal of Clinical Oncology. 31(1). 49–54. 42 indexed citations
15.
Rozell, Joshua C., et al.. (2005). The Effect of Lubricant Eye Drops on Ocular Wavefront Aberrations. Journal of Refractive Surgery. 21(6). 709–715. 8 indexed citations
16.
McKenna, Robert J., Joshua O. Benditt, Malcolm M. DeCamp, et al.. (2004). Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery. Journal of Thoracic and Cardiovascular Surgery. 127(5). 1350–1360. 64 indexed citations
17.
Sciurba, Frank C., Gerard J. Criner, Shing M. Lee, et al.. (2003). Six-Minute Walk Distance in Chronic Obstructive Pulmonary Disease: Reproducibility and Effect of Walking Course Layout and Length. American Journal of Respiratory and Critical Care Medicine. 167(11). 1522–1527. 300 indexed citations
18.
Smith, B. Douglas, Richard J. Jones, Shing M. Lee, et al.. (2002). Autologous bone marrow transplantation with 4‐hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10‐year experience. British Journal of Haematology. 117(4). 907–913. 11 indexed citations
19.
Cummings, Kristin J., Shing M. Lee, Emily West, et al.. (2001). Interferon and Ribavirin vs Interferon Alone in the Re-treatment of Chronic Hepatitis C Previously Nonresponsive to Interferon. JAMA. 285(2). 193–193. 116 indexed citations
20.
Akpek, Görgün, Shing M. Lee, Viki Anders, & Georgia B. Vogelsang. (2001). A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation. 7(9). 495–502. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heloisa P. Soares Breakdown of academic impact, for papers by Patrik Finne Breakdown of academic impact, for papers by Julien Péron Breakdown of academic impact, for papers by Yann De Rycke Breakdown of academic impact, for papers by Benoît You Breakdown of academic impact, for papers by J. Michaelis Breakdown of academic impact, for papers by Xiaofei Wang Breakdown of academic impact, for papers by Fay Cafferty Breakdown of academic impact, for papers by Mohamad Bassam Sonbol Breakdown of academic impact, for papers by Stefania Galimberti
Rankless by CCL
2026